Internet of Things - IOT

This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that ca...

Open Source Innovation in the context of pharma and biotech is an issue based deliverable that gives an overview of this space and analyses the key drivers and barriers of this area. It gives an overview of the key problems faced by the pharmaceutical industry today, past, present and future strategies to tackle these problems, new strategies to im...

This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.

This research service provides insights into M&A activities, trends and strategic analysis in the pharma- biotech space.

This research service aims to profile some of the promising biotech companies in Europe across different countries and segments.

This research service provides the market information on the global radiotherapy and radiosurgery markets, with specific focus on the United States.

This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifyin...

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product usage: oncology, autoimmune and inflammatory disorders, or...

This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. It includes technology trends, challenges, drivers, restraints, competitive structure, strategic recommendations and list of market participants.